Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
16.47x1.12x0.09x2.02x8.19x11.15x-.--% 7.36B
25.81x3.93x2.12x5.47x16.36x19.3x1.85% 76.41B
52.3x5.81x2x12.4x29.65x40.61x-.--% 52.15B
29.62x2.74x-4.47x4.45x14.68x22.03x0.91% 33.96B
11.32x1x514.28x2.21x6.29x7.26x-.--% 18.54B
308.23x8.84x-0.63x9.74x148.87x448.34x-.--% 16.54B
847.64x70.05x-14.14x95.11x185.6x190.13x - 15.41B
15.1x2.6x0.01x2.06x7.12x7.01x-.--% 13.22B
614.62x - 22.01x - - - 0.04% 11.07B
16.34x1.65x0.31x2.82x9.42x11.04x-.--% 10.59B
20.86x2.14x1.04x3.72x10.08x15.74x-.--% 10.08B
-12.83x-3.89x-1.56x20.6x-20.3x-18.62x-.--% 7.6B
36.47x1.44x-0.97x2.2x18.33x18.37x0.45% 6.39B
10.04x2.56x0.08x3.23x7.96x14.44x1.23% 6.45B
17.95x1.32x1.18x4.42x14.16x15.93x-.--% 6.27B
16.88x1.67x-3.46x - - - - 5.78B
22.32x3x2.25x4.93x12.17x12.5x0.41% 5.27B
-28.81x-664.88x0.71x8.14x-36.16x-30.66x-.--% 5.08B
Average 112.24x -32.88x 28.94x 11.47x 27.03x 49.04x 0.31% 17.12B
Weighted average by Cap. 103.72x -4.46x 31.36x 11.26x 31.14x 52.69x 0.65%
Biopharmaceuticals